ATTD Diabetes Talks: Long-Acting Insulin Uncovered

What’s Next in Long-Acting Insulin Therapy?

Stay at the forefront of diabetes care with ATTD Diabetes Talks: Long-Acting Insulin Uncovered — a new ATTD podcast series designed for healthcare professionals who want real-world insights, expert guidance, and actionable knowledge on long-acting insulin therapy.

New episode every Tuesday!

SUBSCRIBE NOW

🎧 About the Podcast

Hosted by diabetes advocate and author Ginger Vieira and powered by ATTD, this series features conversations with top experts — from CDCESs and PharmDs to pediatric endocrinologists and individuals living with diabetes.

Each episode will dive deep into:

  • The latest trends in long-acting insulin therapy
  • Clinical applications and patient outcomes
  • Strategies for patient selection and engagement
  • Real-world stories and lessons from the field

🎙️ Episode 1: Introduction to Long-Acting Insulin Therapy

Special Guest: Jennifer Okemah, RD, CDCES

With nearly two decades of experience as a Registered Dietitian and Certified Diabetes Care and Education Specialist, Jennifer brings expert insights into how long-acting insulin has evolved — and how it’s making a real difference for patients and clinicians alike.

Learning Outcomes:

  • Develop a thorough comprehension of long-acting insulin therapy.
  • Recognize the benefits and role of long-acting insulin in diabetes management.
  • Understand the evolving landscape of long-acting insulin therapies.

🎙️ Episode 2: Understanding the Benefits of Long-Acting Insulin

Special Guest: Dr. Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES

Diana Isaacs is a diabetes advocate and the Director of Education & Training in Diabetes Technology at the Cleveland Clinic. She is also a Fellow of the Association of Diabetes Care and Education Specialists (FADCES) and the American College of Clinical Pharmacy (FCCP).

Learning Outcomes:

  • Understand the pharmacokinetics and pharmacodynamics of long-acting insulin.
  • Learn how long-acting insulin improves blood glucose control and reduces injection burden.
  • Explore emerging once-weekly insulin formulations and their impact on care.

🎙️ Episode 3: Patient Selection Criteria for Long-Acting Insulin Therapy

Special Guest: Dr. Ladan Davallow

Ladan Davallow is a Pediatric Endocrinologist and Type 1 Diabetes Consultant at the Medical University of South Carolina. She is also the co-founder of EndoMD Health, a Virtual Pediatric Endocrine Care Practice.

Learning Outcomes:

  • Identify key factors influencing patient selection for long-acting insulin therapy.
  • Evaluate the role of insulin resistance, lifestyle, and treatment goals in therapy decisions.
  • Apply real-world examples to inform clinical decisions in diabetes care.

🎙️ Episode 4: Initiating, Titrating, and Monitoring Long-Acting Insulin

Special Guest: Aimee Jose, RD, CDCES

Aimée José is the Principal Clinical Educator at Codex Health. She is a skilled Diabetes Educator with extensive expertise in clinical diabetes care and technology.

Learning Outcomes:

  • Understand key factors in initiating, titrating, and monitoring long-acting insulin.
  • Learn step-by-step guidance on dose titration, adjustments, and managing side effects.
  • Explore strategies for patient education and improving patient-provider collaboration.

🎙️ Episode 5: Integrating Long-Acting Insulin with Other Therapies 

Special Guest: Dr. Egils Bogdanovics

We discuss combining long-acting insulin with mealtime insulin, oral medications, and GLP-1 receptor agonists, the role of lifestyle modifications in optimizing insulin effectiveness, and the use of CGM data to refine insulin therapy.

Learning Outcomes:

  • Combine long-acting insulin with other diabetes treatments effectively
  • Use lifestyle strategies to optimize insulin therapy
  • Apply CGM data to fine-tune insulin dosing and improve outcomes

🎙️ Episode 6: Updates and Emerging Trends in Long-Acting Insulin Therapy

Special Guest:
Lucia M. Novak, MSN, ANP-BC, BC-ADM

Discussing the latest in long-acting insulin therapy, including new formulations, smart delivery technologies, GLP-1/GIP therapies, and strategies to reduce treatment burden and improve quality of life for people with diabetes.

Learning Outcomes:

  • Highlight recent updates in long-acting insulin therapy
  • Explain emerging insulin formulations and delivery technologies
  • Recognize strategies to ease treatment burden and enhance quality of life

🎙️ Episode 7: Real-World Applications and Success Stories

Special Guests:
Christel Oerum and Real Prince Blue

Ginger Vieira talks with Christel Oerum (T1D) and Real Prince Blue (T2D) about real-world experiences with long-acting insulin, personalized strategies, patient-provider collaboration, and balancing diabetes care with lifestyle.

Learning Outcomes:

  • Highlight challenges in real-world insulin therapy
  • Explain how personalized strategies and collaboration improve outcomes
  • Identify ways to balance diabetes care with lifestyle choices

🎙️ Episode 8: Common Questions Answered; Advancing Long-Acting Insulin in Practice

Special Guests: Dr. David Ahn

In the final episode, we cover challenges in diabetes management, adjusting insulin doses, Time in Tight Range (TITR), fasting, GLP-1 therapy, weekly insulin injections, hypoglycemia risk, personalized approaches, and diabetes care in athletes.

Learning Outcomes:

  • Adjust insulin and manage diabetes challenges
  • Apply TITR, hypoglycemia, and GLP-1 considerations
  • Use personalized strategies for diverse patient populations

Get expert insights, one conversation at a time.

🎙️ Start listening today. Empower your practice tomorrow.

This series is supported by Eli Lilly and Company.